Análisis
Análisis en profundidad de mercados farmacéuticos, cadenas de suministro, tecnología y regulación
#regulatory ×
Análisis
13 sept 2026•1 min de lectura
South Korea Bio‑Health Exports Hit $1.41 B in August, +22.3% YoY
Korea’s bio‑health industry posted its highest August export ever, $1.41 billion, a 22.3% increase from last year, while cumulative 2026 exports reached $12.11 billion.
1
Análisis
1 sept 2026•1 min de lectura
Samjin Pharma to Normalize HydraSec Supply After MFDS Pediatric Indication Withdrawal
Following MFDS removal of pediatric use for diacetyl hexyl smectite, demand shifted to HydraSec, causing shortages; Samjin Pharma expects supply normalization this week.